메뉴 건너뛰기




Volumn 13, Issue 3, 2013, Pages 140-152

When the going gets tough: How to select patients with Parkinson's disease for advanced therapies

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; APOMORPHINE; CARBIDOPA; CARBIDOPA, LEVODOPA DRUG COMBINATION; LEVODOPA;

EID: 84877666029     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/practneurol-2012-000463     Document Type: Review
Times cited : (49)

References (33)
  • 1
    • 84865445563 scopus 로고    scopus 로고
    • Lack of information and access to advanced treatment for Parkinson's disease patients
    • Lökk J. Lack of information and access to advanced treatment for Parkinson's disease patients. J Multidisciplinary Healthc 2011;4:433-9.
    • (2011) J Multidisciplinary Healthc , vol.4 , pp. 433-439
    • Lökk, J.1
  • 2
    • 0035353725 scopus 로고    scopus 로고
    • Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
    • Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001;16:448-58.
    • (2001) Mov Disord , vol.16 , pp. 448-458
    • Ahlskog, J.E.1    Muenter, M.D.2
  • 3
    • 79957652863 scopus 로고    scopus 로고
    • The treatment of early Parkinson's disease: Levodopa rehabilitated
    • Vlaar A, Hovestadt A, van Laar T, et al. The treatment of early Parkinson's disease: levodopa rehabilitated. Pract Neurol 2011;11:145-52.
    • (2011) Pract Neurol , vol.11 , pp. 145-152
    • Vlaar, A.1    Hovestadt, A.2    van Laar, T.3
  • 4
    • 41449108899 scopus 로고    scopus 로고
    • The sensitivity and specificity of the 9-item Wearing-off Questionnaire
    • Stacy M A, Murphy JM, Greeley DR, et al. The sensitivity and specificity of the 9-item Wearing-off Questionnaire. Parkinsonism Relat Disord 2008;14:205-12.
    • (2008) Parkinsonism Relat Disord , vol.14 , pp. 205-212
    • Stacy, M.A.1    Murphy, J.M.2    Greeley, D.R.3
  • 5
    • 58149133708 scopus 로고    scopus 로고
    • The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease
    • Stocchi F. The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease. Parkinsonism Relat Disord 2009;15(Suppl 1):S9-15.
    • (2009) Parkinsonism Relat Disord , vol.15 , Issue.SUPPL. 1
    • Stocchi, F.1
  • 7
    • 84870057900 scopus 로고    scopus 로고
    • Impulse control and related disorders in Parkinson's disease
    • Weintraub D, Nirenberg MJ. Impulse control and related disorders in Parkinson's disease. Neurodegener Dis 2013;11:63-71.
    • (2013) Neurodegener Dis , vol.11 , pp. 63-71
    • Weintraub, D.1    Nirenberg, M.J.2
  • 8
    • 77953206789 scopus 로고    scopus 로고
    • Surgical management of Parkinson's disease
    • Foltynie T, Hariz MI. Surgical management of Parkinson's disease. Expert Rev Neurother 2010;10:903-14.
    • (2010) Expert Rev Neurother , vol.10 , pp. 903-914
    • Foltynie, T.1    Hariz, M.I.2
  • 9
    • 0025169590 scopus 로고
    • Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
    • Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-1438.
    • (1990) Science , vol.249 , pp. 1436-1438
    • Bergman, H.1    Wichmann, T.2    Delong, M.R.3
  • 10
    • 0022474704 scopus 로고
    • Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: Preliminary observations
    • Kurlan R, Rubin AJ, Miller C, et al. Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations. Ann Neurol 1986;20:262-5.
    • (1986) Ann Neurol , vol.20 , pp. 262-265
    • Kurlan, R.1    Rubin, A.J.2    Miller, C.3
  • 11
    • 33750725397 scopus 로고    scopus 로고
    • Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease
    • Nyholm D. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease. Expert Rev Neurother 2006;6:1403-11.
    • (2006) Expert Rev Neurother , vol.6 , pp. 1403-1411
    • Nyholm, D.1
  • 12
    • 70450230345 scopus 로고    scopus 로고
    • Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease
    • Clarke CE, Worth P, Grosset D, et al. Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease. Parkinsonism Relat Disord 2009;15:728-41.
    • (2009) Parkinsonism Relat Disord , vol.15 , pp. 728-741
    • Clarke, C.E.1    Worth, P.2    Grosset, D.3
  • 13
    • 52649108045 scopus 로고    scopus 로고
    • Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
    • Ruiz PJ García, Ignacio A Sesar, Pensado B Ares, et al. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study. Mov Disord 2008;23:1130-6.
    • (2008) Mov Disord , vol.23 , pp. 1130-1136
    • García, R.P.J.1    Sesar, I.A.2    Ares, P.B.3
  • 14
    • 20144366287 scopus 로고    scopus 로고
    • Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single-dose challenges
    • Katzenschlager R, Hughes A, Evans A, et al. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges. Mov Disord 2005;20:151-7.
    • (2005) Mov Disord , vol.20 , pp. 151-157
    • Katzenschlager, R.1    Hughes, A.2    Evans, A.3
  • 15
    • 58149385649 scopus 로고    scopus 로고
    • Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: A randomized controlled trial
    • Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73.
    • (2009) JAMA , vol.301 , pp. 63-73
    • Weaver, F.M.1    Follett, K.2    Stern, M.3
  • 16
    • 33748139412 scopus 로고    scopus 로고
    • A randomized trial of deep-brain stimulation for Parkinson's disease
    • Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
    • (2006) N Engl J Med , vol.355 , pp. 896-908
    • Deuschl, G.1    Schade-Brittinger, C.2    Krack, P.3
  • 17
    • 77952320903 scopus 로고    scopus 로고
    • Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): A randomised, open-label trial
    • Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010;9:581-91.
    • (2010) Lancet Neurol , vol.9 , pp. 581-591
    • Williams, A.1    Gill, S.2    Varma, T.3
  • 18
    • 2542571133 scopus 로고    scopus 로고
    • Long-term results of bilateral pallidal stimulation in Parkinson's disease
    • Volkmann J, Allert N, Voges J, et al. Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol 2004;55:871-5.
    • (2004) Ann Neurol , vol.55 , pp. 871-875
    • Volkmann, J.1    Allert, N.2    Voges, J.3
  • 19
    • 77953169733 scopus 로고    scopus 로고
    • Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease
    • Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-91.
    • (2010) N Engl J Med , vol.362 , pp. 2077-2091
    • Follett, K.A.1    Weaver, F.M.2    Stern, M.3
  • 20
    • 0242658923 scopus 로고    scopus 로고
    • Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease
    • Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349:1925-34.
    • (2003) N Engl J Med , vol.349 , pp. 1925-1934
    • Krack, P.1    Batir, A.2    van Blercom, N.3
  • 21
    • 38049079782 scopus 로고    scopus 로고
    • Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease
    • Valldeoriola F, Morsi O, Tolosa E, et al. Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease. Mov Disord 2007;22:2183-91.
    • (2007) Mov Disord , vol.22 , pp. 2183-2191
    • Valldeoriola, F.1    Morsi, O.2    Tolosa, E.3
  • 22
    • 84871364493 scopus 로고    scopus 로고
    • Randomised, double-blind, double dummy study of continuous infusion of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Efficacy and safety
    • Olanow CW, Antonini A, Kieburtz K, et al. Randomised, double-blind, double dummy study of continuous infusion of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: efficacy and safety. Mov Disord 2012;27: S131-2.
    • (2012) Mov Disord , vol.27
    • Olanow, C.W.1    Antonini, A.2    Kieburtz, K.3
  • 23
    • 80052729549 scopus 로고    scopus 로고
    • A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson's disease in the UK
    • Lowin J, Bergman A, Chaudhuri KR, et al. A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson's disease in the UK. J Med Econ 2011;14:584-93.
    • (2011) J Med Econ , vol.14 , pp. 584-593
    • Lowin, J.1    Bergman, A.2    Chaudhuri, K.R.3
  • 25
    • 84877646050 scopus 로고    scopus 로고
    • Cost analysis of the treatments for patients with advanced Parkinson's disease
    • Valldeoriola F, Puig-Junoy J, Puig-Peiró R. Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study. J Med Econ 2013;16:191-201.
    • (2013) SCOPE Study. J Med Econ , vol.16 , pp. 191-201
    • Valldeoriola, F.1    Puig-Junoy, J.2    Puig-Peiró, R.3
  • 26
    • 73049100901 scopus 로고    scopus 로고
    • Pros and cons of apomorphine and L-dopa continuous infusion in advanced Parkinson's disease
    • Antonini A, Odin P. Pros and cons of apomorphine and L-dopa continuous infusion in advanced Parkinson's disease. Parkinsonism Relat Disord 2009;15(Suppl 4):S97-100.
    • (2009) Parkinsonism Relat Disord , vol.15 , Issue.SUPPL. 4
    • Antonini, A.1    Odin, P.2
  • 27
    • 58149393691 scopus 로고    scopus 로고
    • Apomorphine nodules in Parkinson's disease: Best practice considerations
    • Todd A, James C-A. Apomorphine nodules in Parkinson's disease: best practice considerations. Br J Community Nurs 2008;13:457-63.
    • (2008) Br J Community Nurs , vol.13 , pp. 457-463
    • Todd, A.1    James, C.-A.2
  • 28
    • 33745854279 scopus 로고    scopus 로고
    • Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
    • Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21(Suppl 1):S290-304.
    • (2006) Mov Disord , vol.21 , Issue.SUPPL. 1
    • Kleiner-Fisman, G.1    Herzog, J.2    Fisman, D.N.3
  • 29
    • 77955803941 scopus 로고    scopus 로고
    • Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy
    • Urban PP, Wellach I, Faiss S, et al. Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord 2010;25: 1748-52.
    • (2010) Mov Disord , vol.25 , pp. 1748-1752
    • Urban, P.P.1    Wellach, I.2    Faiss, S.3
  • 30
    • 34247547815 scopus 로고    scopus 로고
    • Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
    • Derost P-P, Ouchchane L, Morand D, et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology 2007;68:1345-55.
    • (2007) Neurology , vol.68 , pp. 1345-1355
    • Derost, P.-P.1    Ouchchane, L.2    Morand, D.3
  • 31
    • 0031765885 scopus 로고    scopus 로고
    • Subcutaneous apomorphine in late stage Parkinson's disease: A long term follow up
    • Pietz K, Hagell P, Odin P. Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up. J Neurol Neurosurg Psychiatry 1998;65:709-16.
    • (1998) J Neurol Neurosurg Psychiatry , vol.65 , pp. 709-716
    • Pietz, K.1    Hagell, P.2    Odin, P.3
  • 32
    • 79959367266 scopus 로고    scopus 로고
    • Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: A review
    • Broen M, Duits A, Visser-Vandewalle V, et al. Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat Disord 2011;17:413-17.
    • (2011) Parkinsonism Relat Disord , vol.17 , pp. 413-417
    • Broen, M.1    Duits, A.2    Visser-Vandewalle, V.3
  • 33
    • 84858629248 scopus 로고    scopus 로고
    • Deep brain stimulation of globus pallidus interna, subthalamic nucleus, and pedunculopontine nucleus for Parkinson's disease: Which target?
    • Follett KA, Torres-Russotto D. Deep brain stimulation of globus pallidus interna, subthalamic nucleus, and pedunculopontine nucleus for Parkinson's disease: which target? Parkinsonism Relat Disord 2012;18(Suppl 1): S165-7.
    • (2012) Parkinsonism Relat Disord , vol.18 , Issue.SUPPL. 1
    • Follett, K.A.1    Torres-Russotto, D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.